| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | 3KUM2721U9 |
| InChI Key | CFMYXEVWODSLAX-QOZOJKKESA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C11H17N3O8 |
| Molecular Weight | 319.27 |
| AlogP | -5.52 |
| Hydrogen Bond Acceptor | 11.0 |
| Hydrogen Bond Donor | 8.0 |
| Number of Rotational Bond | 1.0 |
| Polar Surface Area | 190.25 |
| Molecular species | BASE |
| Aromatic Rings | 0.0 |
| Heavy Atoms | 22.0 |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Ion channel
Voltage-gated ion channel
Voltage-gated sodium channel
|
- | 4-14 | 2 | - | 79-87 |
| Mesh Heading | Maximum Phase | Reference |
|---|---|---|
| Neuralgia; Peripheral Nervous System Diseases | Phase 2 | ClinicalTrials |
| Cancer Pain | Phase 3 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 4368-28-9 |
| ChEMBL | CHEMBL507974 |
| FDA SRS | 3KUM2721U9 |
| Guide to Pharmacology | 2616 |
| PDB | 9SR |
| PubChem | 11174599 |
| SureChEMBL | SCHEMBL6406675 |
| ZINC | ZINC000013780673 |